According to FutureWise analysis the market for Anticonvulsants in 2023 is US$ 25.17 billion, and is expected to reach US$ 30.96 billion by 2031 at a CAGR of 2.60%.
Anticonvulsants, also known as antiseizure drugs or antiepileptic drugs, are medicines usually used to control or prevent seizures or a series of seizures. They provide comfort from the occurring symptoms and do not change the duration of epilepsy. Epilepsy is a group of interconnected disorders in the brain's electrical systems that are indicated by a tendency to cause recurrent seizures. Seizures cause changes in movement, sensation, behavior, or awareness, including loss of consciousness and convulsions, which last from a few seconds to a few minutes in most people. Seizures may occur in children and adults. Also, antiseizure medications appear to disrupt the overactive transmission of pain signals transmitted from damaged nerves (neuropathy) or overly sensitized nerves, as in fibromyalgia. Anticonvulsants are also used to treat nerve pain and bipolar disorder.
Anticonvulsants comprise a very large family of drugs and are available in different types. Some of them are Barbiturates, Hydantoins, Benzodiazepines, and others. Barbiturates are a class of sedative-hypnotic drugs that are used as anticonvulsants to manage seizure conditions, to induce anesthesia in surgical processes, as anxiolytics to reduce anxiety, and to manage insomnia. Sedatives are medications that help calm down and relax. Barbiturates improve the effect of a chemical called GABA (gamma-aminobutyric acid), which is the central inhibitory neurotransmitter in the brain, by attaching to its receptor.
FutureWise Market Research has published a report that provides an insightful analysis anticonvulsants market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.
According to the analysis conducted by FutureWise research analysts, anticonvulsants market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.